Phio Pharmaceuticals Corp. Interest Expense 2011-2026 | PHIO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Phio Pharmaceuticals Corp.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
2 K	6 K	-8 K	-	-	-	-	-	-10 K	6 K	-2 K	9 K	24 K	125 K	2.55 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.55 M	-10 K	270 K

Quarterly Interest Expense Phio Pharmaceuticals Corp.

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6 K	-1 K	7 K	-	-2 K	-2 K	-	-	-1 K	10 K	6 K	-	2 K	-3 K	-3 K	-	53 K	70 K	1 K	-	123 K	955 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
955 K	-3 K	72 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	9.34 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
Athira Pharma ATHA	1.24 M	-	-	$ 269 M	USA
Enlivex Therapeutics Ltd. ENLV	1.93 M	$ 0.77	-4.12 %	$ 35.2 M	Israel
Exelixis EXEL	-198 K	$ 48.16	4.22 %	$ 13.1 B	USA
BioNTech SE BNTX	14.2 M	$ 94.13	1.19 %	$ 22.8 B	Germany
Fortress Biotech FBIO	17.6 M	$ 2.39	-0.42 %	$ 66.7 M	USA
Forte Biosciences FBRX	-396 K	$ 24.02	-8.22 %	$ 311 M	USA
Compugen Ltd. CGEN	281 K	$ 2.9	1.4 %	$ 271 M	Israel
ACADIA Pharmaceuticals ACAD	1.82 M	$ 22.4	-0.71 %	$ 3.71 B	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	3.49 M	$ 3.14	-	$ 653 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 3.51	-0.85 %	$ 5.78 M	Israel
Gilead Sciences GILD	-1 M	$ 131.33	-2.04 %	$ 163 B	USA
Genprex GNPX	38 K	$ 0.87	0.58 %	$ 811 K	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	8 K	-	-	$ 28.6 M	USA
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	443 K	$ 21.17	2.47 %	$ 2.69 B	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	-27 K	-	-	$ 8.42 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
CRISPR Therapeutics AG CRSP	86.6 M	$ 54.83	4.6 %	$ 4.93 B	Schweiz
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	36.7 M	$ 1.57	-2.48 %	$ 418 M	Britain